Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Dehzad, T. Bopp, S. Reuter, A. Heinz, M. Sieren, R. Wiewrodt, M. Stassen, R. Buhl, E. Schmitt, C. Taube (Mainz, Germany). PDE-4-inhibitor rolipram supports treg-mediated suppression in a murine model of allergic airway disease. Eur Respir J 2008; 32: Suppl. 52, 3704

Member's Comments

No comment yet.

Related content which might interest you: Narirutin inhibits airway inflammation in an allergic mouse model Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease Source: Eur Respir J 2007; 30: Suppl. 51, 60s Year: 2007 Characterisation of type two immune responses in a murine model of allergic airway disease Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 20s Year: 2001 Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 HIF-1α inhibitor, 2ME2, attenuates airway inflammation and hyperresponsiveness in allergic airway disease Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 A role of fungal extracts on allergic airway inflammation in the ovalbumin-induced asthma model Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Estrogen prevents airway hyperresponsiveness in a murine model of allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 433s Year: 2006 ST2 gene knockout attenuates allergic airways disease Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 The PAR2-activating peptide SLIGRL inhibits airway hyper-responsiveness and eosinophilia in an acute murine model of allergic asthma Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology Year: 2004 The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 Development of a mouse model of airway inflammation and remodeling in experimental asthma Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Pharmacological characterization of the protective effect of mepolizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Effects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation Year: 2008 Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Pharmacological characterization of the protective effect of benralizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Murine models of asthma Source: Eur Respir J 2003; 22: 374-382 Year: 2003